{"id":6956,"date":"2021-11-05T10:03:06","date_gmt":"2021-11-05T09:03:06","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf"},"modified":"2021-11-05T10:06:36","modified_gmt":"2021-11-05T09:06:36","slug":"211103_maat-pharma_resultats_press-release-fr_-final-3-2","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/maat-pharma-announces-successful-initial-public-offering-on-the-regulated-market-of-euronext-paris\/211103_maat-pharma_resultats_press-release-fr_-final-3-2\/","title":{"rendered":"211103_MaaT Pharma_R\u00e9sultats_Press Release FR_ Final-3"},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-6956","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>211103_MaaT Pharma_R\u00e9sultats_Press Release FR_ Final-3 | Seventure<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf\",\"url\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf\",\"name\":\"211103_MaaT Pharma_R\u00e9sultats_Press Release FR_ Final-3 | Seventure\",\"isPartOf\":{\"@id\":\"https:\/\/www.seventure.fr\/en\/#website\"},\"datePublished\":\"2021-11-05T09:03:06+00:00\",\"dateModified\":\"2021-11-05T09:06:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.seventure.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris\",\"item\":\"https:\/\/www.seventure.fr\/en\/maat-pharma-announces-successful-initial-public-offering-on-the-regulated-market-of-euronext-paris\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"211103_MaaT Pharma_R\u00e9sultats_Press Release FR_ Final-3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.seventure.fr\/en\/#website\",\"url\":\"https:\/\/www.seventure.fr\/en\/\",\"name\":\"Seventure\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.seventure.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"211103_MaaT Pharma_R\u00e9sultats_Press Release FR_ Final-3 | Seventure","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf","url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf","name":"211103_MaaT Pharma_R\u00e9sultats_Press Release FR_ Final-3 | Seventure","isPartOf":{"@id":"https:\/\/www.seventure.fr\/en\/#website"},"datePublished":"2021-11-05T09:03:06+00:00","dateModified":"2021-11-05T09:06:36+00:00","breadcrumb":{"@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.seventure.fr\/en\/"},{"@type":"ListItem","position":2,"name":"MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris","item":"https:\/\/www.seventure.fr\/en\/maat-pharma-announces-successful-initial-public-offering-on-the-regulated-market-of-euronext-paris\/"},{"@type":"ListItem","position":3,"name":"211103_MaaT Pharma_R\u00e9sultats_Press Release FR_ Final-3"}]},{"@type":"WebSite","@id":"https:\/\/www.seventure.fr\/en\/#website","url":"https:\/\/www.seventure.fr\/en\/","name":"Seventure","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seventure.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf'><img loading=\"lazy\" decoding=\"async\" width=\"212\" height=\"300\" src=\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3-pdf-212x300.jpg\" class=\"attachment-medium size-medium\" alt=\"\" \/><\/a><\/p>\n"},"caption":{"rendered":""},"alt_text":"","media_type":"file","mime_type":"application\/pdf","media_details":{"sizes":{"thumbnail":{"file":"211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3-pdf-106x150.jpg","width":106,"height":150,"mime_type":"image\/jpeg","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3-pdf-106x150.jpg"},"medium":{"file":"211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3-pdf-212x300.jpg","width":212,"height":300,"mime_type":"image\/jpeg","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3-pdf-212x300.jpg"},"large":{"file":"211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3-pdf-724x1024.jpg","width":724,"height":1024,"mime_type":"image\/jpeg","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3-pdf-724x1024.jpg"},"full":{"file":"211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3-pdf.jpg","width":1058,"height":1497,"mime_type":"application\/pdf","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3-pdf.jpg"}}},"post":6958,"source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_R\u00e9sultats_Press-Release-FR_-Final-3.pdf","_links":{"self":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media\/6956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/comments?post=6956"}]}}